CPA1, carboxypeptidase A1, 1357

N. diseases: 61; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0087169
Disease: Withdrawal Symptoms
Withdrawal Symptoms
0.010 Biomarker phenotype BEFREE The aim of this study was to investigate the effects of the selective A<sub>1</sub> receptor agonist CPA (N<sup>6</sup> -cyclopentyladenosine) on withdrawal symptoms, and the concentration of dopamine and noradrenaline in the nucleus accumbens and locomotor activity behavior during naloxone-precipitated withdrawal in morphine-dependent rats. 31808190 2020
CUI: C0206733
Disease: Strawberry nevus of skin
Strawberry nevus of skin
0.010 Biomarker disease BEFREE To assess the practicality of 3-D power Doppler angiography (3-D-CPA) for local drug perfusion dosage guidance of refractory infantile hemangioma (IH) treatment, 47 cases (48 lesions) of refractory IH were selected for local bleomycin infusion (once a month). 31810804 2020
CUI: C0848027
Disease: internal lesion
internal lesion
0.010 Biomarker disease BEFREE Three-dimensional CPA can provide abundant information on internal lesions. 31810804 2020
CUI: C1856184
Disease: HEMIHYPERPLASIA, ISOLATED
HEMIHYPERPLASIA, ISOLATED
0.010 Biomarker disease BEFREE To assess the practicality of 3-D power Doppler angiography (3-D-CPA) for local drug perfusion dosage guidance of refractory infantile hemangioma (IH) treatment, 47 cases (48 lesions) of refractory IH were selected for local bleomycin infusion (once a month). 31810804 2020
CUI: C4317089
Disease: Infantile hemangioma
Infantile hemangioma
0.010 Biomarker disease BEFREE To assess the practicality of 3-D power Doppler angiography (3-D-CPA) for local drug perfusion dosage guidance of refractory infantile hemangioma (IH) treatment, 47 cases (48 lesions) of refractory IH were selected for local bleomycin infusion (once a month). 31810804 2020
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis
0.010 Biomarker disease BEFREE RA subgroups, according to the results of CRP and CPA, produce more and various information than taking RA as a whole group in the estimation of UTEs. 30171597 2019
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.010 Biomarker disease BEFREE In order to assess the effects of resveratrol, progesterone, oestradiol (E2), an anti-testosterone (cyproterone acetate; CPA), a selective ER modulator (tamoxifen; TMX) and ERα/ERβ agonists (propyl pyrazole triol (PPT), diarylpropionitrile (DPN)) on oxidative brain damage and memory impairment due to epileptic seizure, male Wistar rats (n = 120) received one of the treatment choices either in drinking water or intraperitoneally for 31 days, and epileptic seizure was induced on the 28th day by injection of a single-dose of pentylenetetrazole (45 mg kg<sup>-1</sup> ). 31608530 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.010 Biomarker group BEFREE In cases of patients that had a tumor that extended to the CPA, an unsatisfactory facial outcome was noted in 12 (30.0%) patients. 30987492 2019
CUI: C0030286
Disease: Pancreatic Diseases
Pancreatic Diseases
0.010 Biomarker group BEFREE In contrast, similarly to the C57BL/6N mice, the <i>CPA1 null</i> control strain exhibited no signs of pancreatic disease. 30045879 2019
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.010 GeneticVariation phenotype BEFREE In order to assess the effects of resveratrol, progesterone, oestradiol (E2), an anti-testosterone (cyproterone acetate; CPA), a selective ER modulator (tamoxifen; TMX) and ERα/ERβ agonists (propyl pyrazole triol (PPT), diarylpropionitrile (DPN)) on oxidative brain damage and memory impairment due to epileptic seizure, male Wistar rats (n = 120) received one of the treatment choices either in drinking water or intraperitoneally for 31 days, and epileptic seizure was induced on the 28th day by injection of a single-dose of pentylenetetrazole (45 mg kg<sup>-1</sup> ). 31608530 2019
CUI: C0271633
Disease: Disorder of endocrine pancreas
Disorder of endocrine pancreas
0.010 Biomarker group BEFREE Mutant mice were characterised with respect to pancreas pathology and ER stress and compared with C57BL/6N and <i>CPA1 null</i> control mice. 30045879 2019
CUI: C0542476
Disease: Forgetful
Forgetful
0.010 GeneticVariation phenotype BEFREE In order to assess the effects of resveratrol, progesterone, oestradiol (E2), an anti-testosterone (cyproterone acetate; CPA), a selective ER modulator (tamoxifen; TMX) and ERα/ERβ agonists (propyl pyrazole triol (PPT), diarylpropionitrile (DPN)) on oxidative brain damage and memory impairment due to epileptic seizure, male Wistar rats (n = 120) received one of the treatment choices either in drinking water or intraperitoneally for 31 days, and epileptic seizure was induced on the 28th day by injection of a single-dose of pentylenetetrazole (45 mg kg<sup>-1</sup> ). 31608530 2019
CUI: C4317109
Disease: Epileptic Seizures
Epileptic Seizures
0.010 Biomarker phenotype BEFREE In order to assess the effects of resveratrol, progesterone, oestradiol (E2), an anti-testosterone (cyproterone acetate; CPA), a selective ER modulator (tamoxifen; TMX) and ERα/ERβ agonists (propyl pyrazole triol (PPT), diarylpropionitrile (DPN)) on oxidative brain damage and memory impairment due to epileptic seizure, male Wistar rats (n = 120) received one of the treatment choices either in drinking water or intraperitoneally for 31 days, and epileptic seizure was induced on the 28th day by injection of a single-dose of pentylenetetrazole (45 mg kg<sup>-1</sup> ). 31608530 2019
CUI: C0003862
Disease: Arthralgia
Arthralgia
0.010 Biomarker phenotype BEFREE In patients with arthralgia (n = 160), pCHIK-CPA longer than 6 weeks was reported by 44% and longer than 1 year by 26% of cases. 29709007 2018
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.010 GeneticVariation group BEFREE Using the National Latino and Asian American Study we performed three-step logistic regressions to investigate LT-SUD for 1,427 Latinas, following three preplanned steps: (1) childhood physical and sexual abuse (CPA and CSA) with LT-SUD; (2) known correlates as controls; and (3) cultural strength factors. 29624121 2018
CUI: C0015230
Disease: Exanthema
Exanthema
0.010 Biomarker phenotype BEFREE Arthralgia, fever and skin rash were the dominant acute phase symptoms. pCHIK-CPA longer than 1 year affected 26% of cases and was predicted by female gender, high ACR-score and CHIKV-RNA detection beyond 7 days of symptom onset. 29709007 2018
CUI: C0036572
Disease: Seizures
Seizures
0.010 Biomarker phenotype BEFREE The single-site mutants thus faithfully mimic the enzymatic properties of CPB and CPA, respectively. hCPO also shows a preference for Glu over Asp, probably as a consequence of a tighter fitting of the Glu side chain in its S1' substrate-binding pocket. 29636417 2018
CUI: C0085207
Disease: Gestational Diabetes
Gestational Diabetes
0.010 GeneticVariation phenotype BEFREE Pretreatment with EE/CPA was associated with a lower risk of GDM, PIH, and PD. 29525688 2018
CUI: C0813142
Disease: Circadian Rhythm Disorders
Circadian Rhythm Disorders
0.010 Biomarker disease BEFREE Also, since <i>d</i>-CPA and ketotifen have been widely used (e.g., to treat allergy and inflammation) in our daily life and thus raise a possible cause for circadian rhythm disorders by improper use of antihistamines. 29615980 2018
CUI: C2936258
Disease: Peri-Implantitis
Peri-Implantitis
0.010 Biomarker disease BEFREE The top five highly cited terms with > 500 publication counts were peri-implantitis (a mean of 20.17 citations per surveyed article [CPA]), survival rate (19.02 CPA), survival (18.74 CPA), implant failure (16.58 CPA), and success rate (16.53 CPA). 30427954 2018
CUI: C0025286
Disease: Meningioma
Meningioma
0.010 GeneticVariation disease BEFREE Meningioma involving internal auditory canal was only seen in one of the six patients with CPA meningioma.One tumor was totally ossified. 28247112 2017
CUI: C0026946
Disease: Mycoses
Mycoses
0.010 Biomarker group BEFREE The conspicuous presence of CPA and its numerous derivatives in <i>A. flavus</i> cultures raises concerns about the long-term and cumulative toxicological effects of these fungal secondary metabolites and their contributions to the entire <i>A. flavus</i> mycotoxin problem. 28098779 2017
CUI: C0234251
Disease: Inflammatory pain
Inflammatory pain
0.010 Biomarker phenotype BEFREE In addition, mechanical hyperalgesia was significantly reduced in the N6-cyclopentyladenosine (CPA) i.p. or i.m. and endomorphin (EM) i.p. groups.Neither EM i.m. nor EM i.p. exhibited any analgesic effect on thermal hyperalgesia.However, both CPA i.m. and CPA i.p. attenuated thermal hyperalgesia in the mouse inflammatory pain model. 29142219 2017
CUI: C0278877
Disease: Adult Meningioma
Adult Meningioma
0.010 GeneticVariation disease BEFREE Meningioma involving internal auditory canal was only seen in one of the six patients with CPA meningioma.One tumor was totally ossified. 28247112 2017
CUI: C0341471
Disease: Idiopathic chronic pancreatitis
Idiopathic chronic pancreatitis
0.010 GeneticVariation disease BEFREE Herein we performed targeted next-generation sequencing of the CPA1 gene in 1,112 Han Chinese idiopathic chronic pancreatitis (ICP) patients-the largest ICP cohort so far analyzed in a single population-and 1,580 controls. 28497564 2017